Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1412270/000141227019000006/a2018q4earningsrelease8-kc.htm
February 2020
February 2020
December 2019
November 2019
September 2019
August 2019
June 2019
June 2019
May 2019
April 2019
• | Revenue for the fourth quarter of 2018 was $49.8 million, an increase of 13% from $44.2 million in the fourth quarter of 2017. Revenue for fiscal 2018 was $192.3 million, an increase of 10% from $174.1 million in fiscal 2017. |
◦ | Revenue attributable to the US Consumer offering totaled $37.7 million in the fourth quarter of 2018, an increase of 11% from $34.0 million in the fourth quarter of 2017. For the fiscal year, revenue attributable to the US Consumer offering totaled $148.8 million, an increase of 8% from $137.9 million in fiscal 2017. |
◦ | Revenue attributable to our Other businesses totaled $12.1 million in the fourth quarter of 2018, an increase of 18% from $10.2 million in the fourth quarter of 2017. For the fiscal year, revenue attributable to Other businesses totaled $43.5 million, an increase of 20% from $36.2 million in 2017. |
• | Net income was $48.5 million in the fourth quarter of 2018 compared to $7.9 million in the fourth quarter of 2017, an increase of $40.6 million. Net income for fiscal 2018 was $52.9 million, compared to $10.7 million in fiscal 2017, an increase of $42.2 million. For both the quarter and the fiscal year the significant increase was primarily attributable to the reversal of the Company’s valuation allowance related to certain net operating losses and deferred tax assets that are now expected to be realized. |
• | Adjusted EBITDA was $12.7 million in the fourth quarter of 2018, compared to $11.4 million in the fourth quarter of 2017, an improvement of $1.3 million. Adjusted EBITDA for fiscal 2018 was $32.2 million, compared to $23.3 million in fiscal 2017, an increase of $8.9 million. |
• | GAAP EPS (Diluted) was $1.23 in the fourth quarter of 2018, compared to $0.19 in the fourth quarter of 2017. Q4 GAAP EPS (Diluted) was based on 34.0 million weighted average diluted shares outstanding versus 33.1 million in the fourth quarter of 2017. GAAP EPS (Diluted) for the fiscal year was $1.29, compared to $0.22 in fiscal 2017. Q4 YTD GAAP EPS (Diluted) was based on 33.8 million weighted average diluted shares outstanding versus 32.4 million in fiscal 2017. |
• | Non-GAAP EPS (Diluted) was $0.26 in the fourth quarter of 2018, compared to $0.32 in the fourth quarter of 2017. Non-GAAP EPS (Diluted) for the fiscal year was $0.77, compared to $0.69 in fiscal 2017. Note that Non-GAAP EPS excludes the impact of non-cash stock-based compensation, adjustments relating to |
• | The Company ended the year with $127.5 million in cash and cash equivalents and short-term investments. |
• | Our total members grew 16% to 31.7 million at the end of the fourth quarter of 2018, compared to 27.3 million in the same period of 2017. |
• | Total families grew to 18.3 million at the end of the fourth quarter of 2018, an increase of 18% over the same period of 2017, and total caregivers grew to 13.4 million at the end of the fourth quarter of 2018, an increase of 14% over the same period of 2017. |
Q1 2019 Guidance | Full Year 2019 Guidance | ||||||||||||||
Revenue | $ | 52.5 | — | $ | 52.8 | $ | 217.0 | — | $ | 221.0 | |||||
Adjusted EBITDA | $ | 3.7 | — | $ | 4.0 | $ | 33.0 | — | $ | 35.0 | |||||
Non-GAAP EPS | ~ $0.08 | $ | 0.73 | — | $ | 0.78 | |||||||||
Figures in millions except for Non-GAAP EPS | |||||||||||||||
Q1 Non-GAAP EPS based on approximately 40 million weighted average dilutive shares | |||||||||||||||
FY'19 full year Non-GAAP EPS based on 41 million weighted average diluted shares |
Care.com, Inc. | |||||||
Consolidated Balance Sheets | |||||||
(in thousands) | |||||||
December 29, 2018 | December 30, 2017 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 92,432 | $ | 86,728 | |||
Short-term investments | 35,099 | 15,000 | |||||
Accounts receivable (net of allowance of $100 and $102, respectively) (1) | 4,663 | 5,171 | |||||
Unbilled accounts receivable (2) | 6,394 | 5,454 | |||||
Prepaid expenses and other current assets | 7,223 | 4,883 | |||||
Total current assets | 145,811 | 117,236 | |||||
Property and equipment, net | 3,423 | 3,651 | |||||
Intangible assets, net | 4,061 | 1,142 | |||||
Goodwill | 68,176 | 60,281 | |||||
Other non-current assets | 2,859 | 2,066 | |||||
Deferred tax assets | 43,737 | — | |||||
Total assets | $ | 268,067 | $ | 184,376 | |||
Liabilities, redeemable convertible preferred stock, and stockholders' equity | |||||||
Current liabilities: | |||||||
Accounts payable (3) | $ | 3,437 | $ | 1,873 | |||
Accrued expenses and other current liabilities (4) | 20,463 | 17,086 | |||||
Current contingent acquisition consideration | 1,527 | — | |||||
Deferred revenue (5) | 20,176 | 18,626 | |||||
Total current liabilities | 45,603 | 37,585 | |||||
Non-current contingent acquisition consideration | 438 | — | |||||
Deferred tax liabilities | — | 1,292 | |||||
Other non-current liabilities | 6,806 | 5,779 | |||||
Total liabilities | 52,847 | 44,656 | |||||
Series A Redeemable Convertible Preferred Stock, $0.001 par value; 46 shares designated; 46 shares issued and outstanding at December 29, 2018 and December 30, 2017; at aggregate liquidation and redemption value at December 29, 2018 and December 30, 2017 | 53,007 | 50,259 | |||||
Stockholders' equity | |||||||
Preferred Stock, $0.001 par value; 5,000 shares authorized at December 29, 2018 and December 30, 2017, respectively | — | — | |||||
Common stock, $0.001 par value; 300,000 shares authorized; 32,057 and 30,390 shares issued and outstanding at December 29, 2018 and December 30, 2017, respectively | 32 | 30 | |||||
Additional paid-in capital | 286,295 | 266,030 | |||||
Accumulated deficit | (124,122 | ) | (177,145 | ) | |||
Accumulated other comprehensive income | 8 | 546 | |||||
Total stockholders' equity | 162,213 | 89,461 |
Total liabilities, redeemable convertible preferred stock and stockholders' equity | $ | 268,067 | $ | 184,376 |
Care.com, Inc. | |||||||||||||||
Consolidated Statement of Operations | |||||||||||||||
(in thousands, except per share data) | |||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||
December 29, 2018 | December 30, 2017 | December 29, 2018 | December 30, 2017 | ||||||||||||
Revenue (1) | $ | 49,809 | $ | 44,216 | $ | 192,260 | $ | 174,090 | |||||||
Cost of revenue | 11,908 | 8,662 | 42,706 | 35,773 | |||||||||||
Operating expenses: | |||||||||||||||
Selling and marketing (2) | 11,291 | 12,107 | 60,488 | 66,906 | |||||||||||
Research and development | 9,001 | 6,566 | 34,641 | 25,423 | |||||||||||
General and administrative | 11,313 | 9,686 | 44,360 | 35,214 | |||||||||||
Depreciation and amortization | 424 | 418 | 1,669 | 1,684 | |||||||||||
Restructuring charges | 45 | 158 | 613 | 3,136 | |||||||||||
Total operating expenses | 32,074 | 28,935 | 141,771 | 132,363 | |||||||||||
Operating income | 5,827 | 6,619 | 7,783 | 5,954 | |||||||||||
Other income (expense), net | 3 | 282 | (165 | ) | 2,203 | ||||||||||
Income from continuing operations before income taxes | 5,830 | 6,901 | 7,618 | 8,157 | |||||||||||
Benefit from income taxes | (42,680 | ) | (1,003 | ) | (45,272 | ) | (2,506 | ) | |||||||
Net income | 48,510 | 7,904 | 52,890 | 10,663 | |||||||||||
Accretion of Series A Redeemable Convertible Preferred Stock dividends | (685 | ) | (657 | ) | (2,748 | ) | (2,599 | ) | |||||||
Net income attributable to Series A Redeemable Convertible Preferred Stock | (6,542 | ) | (992 | ) | (6,983 | ) | (1,120 | ) | |||||||
Net income attributable to common stockholders | $ | 41,283 | $ | 6,255 | $ | 43,159 | $ | 6,944 | |||||||
Net income per share attributable to common stockholders (Basic) | $ | 1.30 | $ | 0.21 | $ | 1.38 | $ | 0.23 | |||||||
Net income per share attributable to common stockholders (Dilutive) | $ | 1.23 | $ | 0.19 | $ | 1.29 | $ | 0.22 | |||||||
Weighted-average shares used to compute net income per share attributable to common stockholders: | |||||||||||||||
Basic | 31,853 | 30,189 | 31,198 | 29,680 | |||||||||||
Diluted | 33,991 | 33,128 | 33,816 | 32,406 |
Care.com, Inc. | |||||||
Consolidated Statement of Cash Flows | |||||||
(in thousands) | |||||||
Year Ended | |||||||
December 29, 2018 | December 30, 2017 | ||||||
Cash flows from operating activities | |||||||
Net income | $ | 52,890 | 10,663 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | |||||||
Stock-based compensation | 17,374 | 9,693 | |||||
Depreciation and amortization | 2,128 | 2,240 | |||||
Deferred income taxes | (45,638 | ) | (2,983 | ) | |||
Contingent consideration expense | 58 | — | |||||
Change in fair value of contingent consideration | 337 | — | |||||
Loss on impairment of intangible assets | 142 | — | |||||
Foreign currency remeasurement loss (gain) | 976 | (1,838 | ) | ||||
Other non-cash operating expenses | — | 489 | |||||
Changes in operating assets and liabilities, net of effects from acquisitions: | |||||||
Accounts receivable | 477 | (2,349 | ) | ||||
Unbilled accounts receivable | (947 | ) | 95 | ||||
Prepaid expenses and other current assets | (718 | ) | (636 | ) | |||
Other non-current assets | (1,227 | ) | — | ||||
Accounts payable | 1,569 | (638 | ) | ||||
Accrued expenses and other current liabilities | 1,354 | 3,031 | |||||
Deferred revenue | 1,718 | 2,531 | |||||
Other non-current liabilities | 2,274 | 1,751 | |||||
Net cash provided by operating activities | 32,767 | 22,049 | |||||
Cash flows from investing activities | |||||||
Purchases of property and equipment and software | (900 | ) | (792 | ) | |||
Payments for acquisitions, net of cash acquired | (9,815 | ) | — | ||||
Issuance of loan receivable | (175 | ) | — | ||||
Payments for security deposits | — | (33 | ) | ||||
Purchases of short-term investments | (35,099 | ) | (15,000 | ) | |||
Sale of short-term investments | 15,000 | 15,000 | |||||
Net cash used in investing activities | (30,989 | ) | (825 | ) | |||
Cash flows from financing activities | |||||||
Proceeds from exercise of common stock options | 5,584 | 3,906 | |||||
Payments of contingent consideration previously established in purchase accounting | (354 | ) | — | ||||
Net cash provided by financing activities | 5,230 | 3,906 | |||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash | (749 | ) | 420 | ||||
Net increase in cash and cash equivalents and restricted cash | 6,259 | 25,550 | |||||
Cash and cash equivalents and restricted cash, beginning of the period | 89,024 | 63,474 | |||||
Cash and cash equivalents and restricted cash, end of the period | $ | 95,283 | $ | 89,024 | |||
Cash and cash equivalents, end of period | 92,432 | 86,728 |
Restricted cash 1 | 2,851 | 2,296 | |||||
Cash and cash equivalents and restricted cash, end of the period | $ | 95,283 | $ | 89,024 |
Care.com, Inc. | |||||||||||||||
Reconciliation of Adjusted EBITDA & Non-GAAP Income | |||||||||||||||
(in thousands, except per share data) | |||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||
December 29, 2018 | December 30, 2017 | December 29, 2018 | December 30, 2017 | ||||||||||||
(unaudited) | (unaudited) | ||||||||||||||
Net income | $ | 48,510 | $ | 7,904 | $ | 52,890 | $ | 10,663 | |||||||
Federal, state and franchise taxes | (42,596 | ) | (929 | ) | (44,651 | ) | (2,228 | ) | |||||||
Other expense (income), net | (3 | ) | (282 | ) | 165 | (2,203 | ) | ||||||||
Depreciation and amortization | 601 | 539 | 2,128 | 2,240 | |||||||||||
EBITDA | 6,512 | 7,232 | 10,532 | 8,472 | |||||||||||
Stock-based compensation | 4,393 | 3,107 | 17,374 | 9,693 | |||||||||||
Merger and acquisition related costs | 1,572 | 171 | 2,834 | 407 | |||||||||||
Restructuring related costs | 45 | 158 | 613 | 3,136 | |||||||||||
Litigation related costs | 62 | 561 | 239 | 636 | |||||||||||
Software implementation costs | — | 14 | 308 | 471 | |||||||||||
Severance related costs | — | 166 | 67 | 487 | |||||||||||
Impairment of intangible assets | — | — | 142 | — | |||||||||||
Non-recurring professional fees | 120 | — | 120 | — | |||||||||||
Adjusted EBITDA | $ | 12,704 | $ | 11,409 | $ | 32,229 | $ | 23,302 | |||||||
Add back for Non-GAAP Net Income | |||||||||||||||
Federal, state and franchise taxes | (2,113 | ) | 929 | (58 | ) | 2,228 | |||||||||
Other expense, net | 3 | 282 | (165 | ) | 2,203 | ||||||||||
Depreciation and amortization | (601 | ) | (539 | ) | (2,128 | ) | (2,240 | ) | |||||||
Non-GAAP net income | $ | 9,993 | $ | 12,081 | $ | 29,878 | $ | 25,493 | |||||||
Non-GAAP net income per share: | |||||||||||||||
Basic | $ | 0.31 | $ | 0.40 | $ | 0.96 | $ | 0.86 | |||||||
Diluted | $ | 0.26 | $ | 0.32 | $ | 0.77 | $ | 0.69 | |||||||
Weighted-average shares used to compute non-GAAP net income per share : | |||||||||||||||
Basic | 31,853 | 30,189 | 31,198 | 29,680 | |||||||||||
Diluted | 39,039 | 37,915 | 38,864 | 37,192 |
Care.com, Inc. | ||||||||||||||||
Reconciliation of Non-GAAP EPS | ||||||||||||||||
(in thousands, except per share data) | ||||||||||||||||
Three Months Ended | Year Ended | |||||||||||||||
December 29, 2018 | December 30, 2017 | December 29, 2018 | December 30, 2017 | |||||||||||||
(unaudited) | (unaudited) | |||||||||||||||
Weighted-average shares used to compute net income per share: | ||||||||||||||||
Diluted | 39,039 | 37,915 | 38,864 | 37,192 | ||||||||||||
Net income per share (Diluted): | ||||||||||||||||
Net income per share attributable to common stockholders | $ | 1.06 | $ | 0.16 | $ | 1.11 | $ | 0.19 | ||||||||
Impact on net income per share of Series A related costs | 0.19 | 0.04 | 0.25 | 0.10 | ||||||||||||
Adjusted net income per share | $ | 1.24 | $ | 0.21 | $ | 1.36 | $ | 0.29 | ||||||||
Stock-based compensation | 0.11 | 0.08 | 0.45 | 0.26 | ||||||||||||
Merger and acquisition related costs | 0.04 | 0.00 | 0.07 | 0.01 | ||||||||||||
Restructuring related costs | 0.00 | 0.00 | 0.02 | 0.08 | ||||||||||||
Litigation related costs | 0.00 | 0.01 | 0.01 | 0.02 | ||||||||||||
Software implementation costs | — | 0.00 | 0.01 | 0.01 | ||||||||||||
Severance related costs | — | 0.00 | 0.00 | 0.01 | ||||||||||||
Impairment of intangible assets | — | — | 0.00 | — | ||||||||||||
Non-recurring professional fees | 0.00 | — | 0.00 | — | ||||||||||||
Reversal of valuation allowance | (1.15 | ) | — | (1.15 | ) | — | ||||||||||
Non-GAAP net income per share - diluted | $ | 0.26 | $ | 0.32 | $ | 0.77 | $ | 0.69 |
Care.com, Inc. | |||||||
Supplemental Data | |||||||
(in thousands, except monthly average revenue per member) | |||||||
Period Ended | |||||||
December 29, 2018 | December 30, 2017 | ||||||
Total members | 31,724 | 27,312 | |||||
Total families | 18,290 | 15,510 | |||||
Total caregivers | 13,434 | 11,802 | |||||
Paying families - US Consumer Business | 336 | 302 | |||||
Period Ended | |||||||
December 29, 2018 | December 30, 2017 | ||||||
Monthly average revenue per paying family | |||||||
US Consumer Business | $ | 39 | $ | 40 |
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1412270/000141227019000006/a2018q4earningsrelease8-kc.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Care.Com Inc.
Care.Com Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Care.Com Inc provided additional information to their SEC Filing as exhibits
Ticker: CRCMEvents:
CIK: 1412270
Form Type: 8-K Corporate News
Accession Number: 0001412270-19-000006
Submitted to the SEC: Thu Mar 07 2019 6:04:24 AM EST
Accepted by the SEC: Thu Mar 07 2019
Period: Thursday, March 7, 2019
Industry: Personal Services